MarketBeat on MSN

Aclaris Therapeutics maps busy pipeline calendar, plans phase 2 asthma trial for ATI-052

Key Points Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better. Aclaris Therapeutics is preparing a ...

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...

BOXABL Announces First Phase 2 Order with Shelton Development for 203 Boxes in Texas

BOXABL, the technology company focused on transforming residential construction through scalable, factory-built housing, ...

Azafaros Announces Publication of Phase 2 RAINBOW Study Data for Nizubaglustat in Molecular Genetics and Metabolism Journal

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on ...
The Manila Times

Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in a…

First-in-class therapeutic antibody, potravitug, for BK polyomavirus infection showed consistent reduction in viral load and ...

Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis

APEX Part B met all primary and secondary endpoints with high statistical significance; mid-dose zumilokibart planned to advance into Phase 3 ...
Upstream Online

Shell’s LNG Canada gives preliminary green light for phase two expansion

Shell-led LNG Canada has issued a limited notice to proceed to its lead contractors for the proposed second phase for the ...